1. Dykema, Arbor G, Zhang, Jiajia, Cheung, Laurene S, Pardoll, Drew M, Smith, Kellie N. 2023. Lung tumor-infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response. In Science immunology, 8, eadg1487. doi:10.1126/sciimmunol.adg1487. https://pubmed.ncbi.nlm.nih.gov/37713507/
2. Wang, Yawei, Chen, Di, Liu, Yu, Piao, Hai-Long, Liu, Hong-Xu. 2023. Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers. In Cell death & disease, 14, 462. doi:10.1038/s41419-023-05992-w. https://pubmed.ncbi.nlm.nih.gov/37488117/
3. Ye, Chen, Qin, Shengfei, Qiu, Shuang, Chen, Yuangui, Zhou, Tie. . A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma. In Translational andrology and urology, 11, 1691-1705. doi:10.21037/tau-22-711. https://pubmed.ncbi.nlm.nih.gov/36632155/
4. Liu, Zhi-Yong, Lin, Xia-Hui, Guo, Hong-Ying, Dong, Ling, Zhu, Ji-Min. 2024. Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. In International journal of biological sciences, 20, 2763-2778. doi:10.7150/ijbs.93075. https://pubmed.ncbi.nlm.nih.gov/38725845/
5. Riccardi, Carlo, Ronchetti, Simona, Nocentini, Giuseppe. 2018. Glucocorticoid-induced TNFR-related gene (GITR) as a therapeutic target for immunotherapy. In Expert opinion on therapeutic targets, 22, 783-797. doi:10.1080/14728222.2018.1512588. https://pubmed.ncbi.nlm.nih.gov/30107134/
6. Lecerf, Charlotte, Kamal, Maud, Vacher, Sophie, Bieche, Ivan, Le Tourneau, Christophe. 2019. Immune gene expression in head and neck squamous cell carcinoma patients. In European journal of cancer (Oxford, England : 1990), 121, 210-223. doi:10.1016/j.ejca.2019.08.028. https://pubmed.ncbi.nlm.nih.gov/31593831/